EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Myeloid-Derived Suppressor Cells: Implications in Cancer Immunology and Immunotherapy

Juan F Santibanez

Frontiers in Bioscience-Landmark · 20.03.2025 · 30 (3)

DOI: 10.31083/fbl25203 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 20.03.2025. Verfasst von Juan F Santibanez. Beteiligte Einrichtung: Group for Molecular Oncology, Institute for Medical Research, National Institute of the Republic of Serbia, University of Belgrade, 11129 Belgrade, S…. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells, Neoplasms, Immunotherapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myeloid-derived suppressor cells (MDSCs) are believed to be key promoters of tumor development and are recognized as a hallmark of cancer cells’ ability to evade the immune system evasion. MDSC levels often increase in peripheral blood and the tumor microenvironment (TME). These cells exert immunosuppressive functions, weakening the anticancer immune surveillance system, in part by repressing T-cell immunity. Moreover, MDSCs may promote tumor progression and interact with cancer cells, increasing MDSC expansion and favoring an immunotolerant TME. This review analyzes the primary roles of MDSCs in cancer and T-cell immunity, discusses the urgent need to develop effective MDSC-targeted therapies, and highlights the potential synergistic combination of MDSC targeting with chimeric antigen receptors and immune checkpoint inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloid-Derived Suppressor CellsNeoplasmsImmunotherapyHumansTumor MicroenvironmentAnimalsT-LymphocytesImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

MDSCT-cell lymphocyte immunosuppressioncancermyeloid-derived suppressor cellstumor progression

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Group for Molecular Oncology, Institute for Medical Research, National Institute of the Republic of Serbia, University of Belgrade, 11129 Belgrade, Serbia.
  • Integrative Center for Biology and Applied Chemistry (CIBQA), Bernardo O'Higgins University, 8370993 Santiago, Chile.

Zitieren

APA

Santibanez, J. F. (2025). Myeloid-Derived Suppressor Cells: Implications in Cancer Immunology and Immunotherapy. Frontiers in Bioscience-Landmark, 30(3). https://doi.org/10.31083/fbl25203

Vancouver

Santibanez JF. Myeloid-Derived Suppressor Cells: Implications in Cancer Immunology and Immunotherapy. Frontiers in Bioscience-Landmark. 2025;30(3). doi:10.31083/fbl25203

BibTeX
@article{Santibanez2025,
  author = {Santibanez, Juan F},
  title = {Myeloid-Derived Suppressor Cells: Implications in Cancer Immunology and Immunotherapy},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2025},
  volume = {30},
  number = {3},
  doi = {10.31083/fbl25203}
}
Kostenlos starten →